Vistin Pharma - Call Transcript 2021

Vistin Pharma ASA: Invitation to Q1 2021 conference call

Oslo, Norway, 16 April 2021

Vistin Pharma ASA will release its first quarter 2021 results on Friday 23(rd)

of April 2021. Vistin Pharma will host a conference call for all shareholders

and interested parties on Friday 23(rd) of April at 08:30 CET. There will be a

Q&A session following the management discussion.

The conference call will be held in Norwegian.

The first quarter conference call will be available via web and audio through

the following access points:

Telephone conference:

Confirmation Code:........ 4598958

International Dial-In:........ +44 (0) 2071 928338

Norway, Oslo:................ +47 21563015

United States, New York: +1 6467413167

Webcast:

https://edge.media-server.com/mmc/p/rso5ngk4

*****

For further information, please contact:

Alexander Karlsen

CFO

+47 97053621

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin

Hydrochloride (API). The Metformin is also available as Direct Compressible

lubricated granules. As a solely dedicated European Metformin producer, Vistin

Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin

Pharma is headquartered in Oslo, Norway, and has highly qualified employees and

a dedicated manufacturing facility in Kragerø.

AI assistant